C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/4985 (2006.01) A61P 9/00 (2006.01)
Patent
CA 2608672
Compounds, tautomers of the compounds, and pharmaceutically acceptable salts of the compounds or tautomers are disclosed, wherein the compounds have the structure of Formula I: wherein R2, X6, Y6, R6, and R8 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, synthetic methods, and intermediates are also disclosed.
Cette invention concerne des composés, des tautomères de ces composés, et des sels pharmaceutiquement acceptables de ces composés ou tautomères. Ces composés possèdent une structure représentée par la formule (I), dans laquelle R2, X6, Y6, R6 et R8 sont définis dans les pièces descriptives de la demande. Des compositions pharmaceutiques correspondantes, des procédés de traitement, des procédés de synthèse et des intermédiaires sont également divulgués.
Bell Andrew Simon
Benson Alan George
Brown David Graham
Brown David Louis
Fobian Yvette Marlene
Pharmacia & Upjohn Company Llc
Sim & Mcburney
LandOfFree
Pyridine [3,4-b] pyrazinones as pde-5 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridine [3,4-b] pyrazinones as pde-5 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine [3,4-b] pyrazinones as pde-5 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1602455